Weatherbie Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Weatherbie Capital’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$11.9M	Sell	168,915 -61,713	-27%	-$4.38M	1.49%	33
2016 Q3	$16.4M	Sell	230,628 -107,160	-32%	-$6.84M	2.06%	22
2016 Q2	$16.5M	Buy	337,788 +36,697	+12%	+$2.37M	2.34%	16
2016 Q1	$19.1M	Buy	301,091 +94,532	+46%	+$6.19M	2.52%	14
2015 Q4	$23.2M	Sell	206,559 -321	-0.2%	-$32.1K	2.72%	14
2015 Q3	$19.9M	Sell	206,880 -52,753	-20%	-$6.04M	2.31%	17
2015 Q2	$26.6M	Buy	+259,633	New	+$20.2M	2.7%	15

Other funds holding RARE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Weatherbie Capital's RARE Position: Q4 2016 in Review

Weatherbie Capital reduced its Ultragenyx Pharmaceutical (RARE) stake by 27% in Q4 2016, selling an estimated $4.38M and leaving 168,915 shares worth $11.9M. The position accounts for 1.49% of the portfolio, ranked #33.

Weatherbie Capital first reported a position in RARE in Q2 2015 and has held it in 7 quarters since. The position peaked at $26.6M in Q2 2015. 174 funds tracked by Wall St. Rank hold RARE as of Q4 2016.

Weatherbie Capital held 168,915 shares of Ultragenyx Pharmaceutical worth $11.9M as of Q4 2016.
Weatherbie Capital sold 61,713 Ultragenyx Pharmaceutical shares in Q4 2016, an estimated $4.38M.
Ultragenyx Pharmaceutical made up 1.49% of Weatherbie Capital's portfolio in Q4 2016, its #33 holding.
Weatherbie Capital first reported a position in Ultragenyx Pharmaceutical in Q2 2015 and has held it in 7 quarters since.
Weatherbie Capital's Ultragenyx Pharmaceutical position peaked at $26.6M in Q2 2015.
174 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2016.

Based on Weatherbie Capital's 13F filing for Q4 2016, filed 14 Feb 2017.